By 2020, Alpha-galactosidase A for Fabry disease is the most unaffordable drug for residents, whose cost of one day's treatment is equivalent to 142.7 days' income of urban residents and 365.2 days' income of rural residents. The gene discussed is GLA; the disease is Fabry disease.